Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Public Health Genomics
|
September 28, 2016
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy
Athanassios Vozikis, David N Cooper, Christina Mitropoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2011
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303
Federico Innocenti, Kouros Owzar, Nancy L Cox, et al.
Nature Communications
|
September 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
Radia M Johnson, Xueping Qu, Chu-Fang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)
Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
Pharmacogenetics and Genomics
|
May 15, 2013
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751
Federico Innocenti, Jacqueline Ramírez, Jennifer Obel, et al.
Molecular Cancer Therapeutics
|
August 5, 2020
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib
Yingmiao Liu, Jing Lyu, Kirsten Bell Burdett, et al.
JAMA Oncology
|
September 17, 2020
Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer
Christopher Mackintosh, Chen Yuan, Fang-Shu Ou, et al.
Scientific Reports
|
November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patients
Federico Innocenti, Chen Jiang, Alexander B Sibley, et al.
JNCI Cancer Spectrum
|
April 8, 2020
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
Justin C Brown, Sui Zhang, Fang-Shu Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)
Donna Niedzwiecki, Wendy L Frankel, Alan P Venook, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Public Health Genomics
|
September 28, 2016
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy
Athanassios Vozikis, David N Cooper, Christina Mitropoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2011
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303
Federico Innocenti, Kouros Owzar, Nancy L Cox, et al.
Nature Communications
|
September 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
Radia M Johnson, Xueping Qu, Chu-Fang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)
Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
Pharmacogenetics and Genomics
|
May 15, 2013
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751
Federico Innocenti, Jacqueline Ramírez, Jennifer Obel, et al.
Molecular Cancer Therapeutics
|
August 5, 2020
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib
Yingmiao Liu, Jing Lyu, Kirsten Bell Burdett, et al.
JAMA Oncology
|
September 17, 2020
Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer
Christopher Mackintosh, Chen Yuan, Fang-Shu Ou, et al.
Scientific Reports
|
November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patients
Federico Innocenti, Chen Jiang, Alexander B Sibley, et al.
JNCI Cancer Spectrum
|
April 8, 2020
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
Justin C Brown, Sui Zhang, Fang-Shu Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)
Donna Niedzwiecki, Wendy L Frankel, Alan P Venook, et al.
Page
of 19